BioArctic
212
SEK
+1,05 %
BIOA B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
7 investorer følger denne virksomhed
+1,05%
+6,27%
+9,45%
+34,52%
-5,69%
-21,31%
+77,85%
+121,99%
+631,03%
BioArctic is a research company. The greatest business focus is found in the research and development of treatments and antibodies for diseases that affect the nervous system. Examples of various diseases mainly include Alzheimer's and Parkinson's. A large part of the research is carried out in collaboration with researchers at universities and hospitals. The company was founded in 2003 and is headquartered in Stockholm, Sweden.
Læs mereMarkedsværdi
18,74 mia. SEK
Aktieomsætning
28,23 mio. SEK
Omsætning
616 mio.
EBIT %
41,01 %
P/E
81,54
Udbytteafkast, %
-
Finanskalender
13.2
2025
Årsrapport '24
21.5
2025
Delårsrapport Q1'25
28.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
BioArctic: First patient dosed in EXIST Phase 2a study in Parkinson's disease
BioArctic: Leqembi® approved in Mexico
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools